Joe Rogan Experience #2579 - Gary Sinise · Aired Nov 10, 2026
Claim summary · not a verbatim quotation
Rogan says ibogaine has helped veterans he knows with trauma symptoms and addiction when other approaches failed.
The finding
What remains unresolved
The personal outcomes are not independently verifiable here. Stanford's prospective study followed 30 male special-operations veterans treated with ibogaine, magnesium and complementary support; a later follow-up reported persistent improvements among 25 respondents. It was not a randomized controlled trial and cannot establish that ibogaine alone caused the changes, works for all veterans or cures addiction. Heart risks require careful study. This is promising preliminary evidence, with Rogan's anecdotal scope preserved.
Read the supporting source · med.stanford.edu ↗Quick answer & review status
Quick answer
Is it true that Rogan says ibogaine has helped veterans he knows with trauma symptoms and addiction when other approaches failed?
We can't say yet. The personal outcomes are not independently verifiable here. Stanford's prospective study followed 30 male special-operations veterans treated with ibogaine, magnesium and complementary support; a later follow-up reported persistent improvements among 25 respondents. It was said on Joe Rogan Experience #2579 - Gary Sinise, aired Nov 10, 2026, at 1:48:44. We haven't independently confirmed who said it. We couldn't settle it from the evidence we captured, so it stays an open question, not a false claim. The supporting source is med.stanford.edu, linked below.
The context belongs here.
No separately verified on-air correction is recorded for this check. That is not a claim that nobody corrected it.
- Attribution
- Not independently confirmed in this record
- Editorial context review
- Not recorded; generated finding
- Coverage
- One selected claim from the episode
Revisions to this check
No dated revision is recorded here. Older checks may predate this log.
Challenge this finding or add context →Keep the evidence coming.
Follow new checks in your RSS reader, or catch up with the weekly briefing on the site.
Email signup is currently unavailable.
Prefer to catch up here? Read the weekly briefing.